<DOC>
	<DOCNO>NCT02307799</DOCNO>
	<brief_summary>The aim RESPECT study gain well understanding prevalence , pathogenesis symptom early chronic obstructive pulmonary disease ( COPD ) . This study seek address follow specific objectives/research question : 1 ) estimate prevalence airflow limitation ( AL ) COPD adult 35-70 year age St.Petersburg Arkhangelsk base sex , age , environmental condition , socioeconomic status smoking status ; 2 ) compare prevalence COPD study population base Global Strategy Diagnosis , Management Prevention COPD ( GOLD ) low limit normal ( LLN ) criteria ; 3 ) identify diagnostic value various sign , symptom background characteristic diagnosis COPD ; 4 ) determine whether difference background characteristic inflammatory biomarkers evident smoker without COPD ; 5 ) describe co-morbidity , functionality global health status cohort newly diagnose COPD patient .</brief_summary>
	<brief_title>A RESearch PrEvalence Diagnosis COPD Its Tobacco-related Etiology</brief_title>
	<detailed_description>Two northwestern Russian Federation ( RF ) city ( St.Petersburg Arkhangelsk ) select RESPECT study . Fifteen primary care center invite participate study . Fifteen investigator ( 10 St.Petersburg 5 Arkhangelsk ) recruit ( predominantly doctor two highly educate nurse ) . All investigator receive study information , include detailed study protocol recent guideline COPD , participate three-week course spirometry clinical diagnosis management obstructive lung disease . The sample size calculate base two goal : 1 ) determine reliable estimate prevalence COPD 2 ) estimate diagnostic value symptom acceptable confidence interval . The sample size RESPECT study estimate use 2828 subject ( base 8 % prevalence COPD RF ) . Assuming anticipated refusal rate 20 % , 3500 participant St.Petersburg 1500 Arkhangelsk invite participate study . The analysis include cross-sectional prospective approach . Prospective analysis perform entire cohort .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>•written consent participate Inclusion criterion cohort component : •100 newly detect person FEV1/FVC less 0.7 less LLN reversibility test . Inclusion criterion casecontrol component : Both case control : •A smoke history 10 packyears base pack/year criterion Test case include 100 participant meet follow criterion : Smokers age 3570 year smoke history &gt; 10 packyears . Completely irreversible airway obstruction base follow criterion : FEV1/FVC &lt; 0.70 accord GOLD criterion FEV1/FVC &lt; LLN . Test control include 100 participant base follow criterion : •Smokers age 3570 year smoke history &gt; 10 pack/years without COPD accord GOLD LLN criterion , without asthma ( absence symptom ) , negative history allergy , free use bronchodilator . COPD exacerbation last 3 month Patient sign inform consent Patient refuse participate</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>tobacco</keyword>
	<keyword>spirometry</keyword>
	<keyword>cohort study</keyword>
	<keyword>case-control study</keyword>
	<keyword>prevalence</keyword>
</DOC>